Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).

被引：0
|
作者：
Abramova, Natalya A. [1 ]
Vladimirova, Liubov Yu [1 ]
Shikhliarova, Alla I. [1 ]
Storozhakova, Anna E. [1 ]
Kova, Valeriya S. Myag [1 ]
机构：
[1] Rostov Sci Res Inst Oncol, Rostov Na Donu, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1070
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).
    Puerto, VL
    Cardenas, J
    Lara, F
    Goana, R
    Silva, A
    Barroso, N
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 299 - 299
  • [2] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [3] The usefulness of FDG-PET in predicting response to neoadjuvant chemotherapy (NCT) in patients with locally-advanced breast cancer (LABC)
    Schneider-Kolsky, M. E.
    Midolo, P.
    Hart, S.
    Stuckey, J.
    Baldey, A.
    Fox, J.
    Rogers, P. A. W.
    Strickland, A.
    Susil, B.
    Ganju, V.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 135 - 135
  • [4] Biological markers to predict response to neoadjuvant chemotherapy (NCT) in patients with locally advanced breast cancer (LABC): Ready for prime time?
    Pino, M. S.
    Fabi, A.
    Tedeschi, M.
    Mottolese, M.
    Papaldo, P.
    Vici, P.
    Ferretti, G.
    Nistico, C.
    Russillo, M.
    Cuppone, F.
    Di Benedetto, A.
    Botti, C.
    Giannarelli, D.
    Cognetti, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] IMMUNOHISTOCHEMICAL PREDICTORS OF PATHOLOGICAL RESPONSE IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER (LABC) UNDERGOING PACLITAXEL-BASED NEOADJUVANT CHEMOTHERAPY (NCT)
    De Rosa, G.
    Montemurro, F.
    Redana, S.
    Ponzone, R.
    Martincich, L.
    Gatti, M.
    Sarotto, I.
    Biglia, N.
    Risio, M.
    Sismondi, P.
    Aglietta, M.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 13 - 14
  • [6] NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST-CANCER (LABC)
    SWAIN, S
    LIPPMAN, M
    BAGLEY, C
    SORACE, R
    WESLEY, M
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 55 - 55
  • [7] Breast magnetic resonance imaging (MRI): a useful tool for therapeutic decision in patients treated for locally Advanced breast cancer (LABC) by neoadjuvant chemotherapy (NCT).
    Gligorov, J
    Chopier, J
    Benchimol, Y
    Barranger, E
    Antoine, M
    Lotz, JP
    Uzan, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 238 - 238
  • [8] Locally advanced breast cancer (LABC): Neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC).
    Wynendaele, W
    Paridaens, R
    Wildiers, J
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S208 - S208
  • [9] Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)?
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 121 - 121
  • [10] Gross and histologic features of locally advanced breast cancer (LABC) after neoadjuvant chemotherapy (NAC).
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 122 - 122
12345